Feixiong Cheng
H指数:92
被引数:5.8万
个人简介
A computational biologist with expertise in analyzing, visualizing, and mining data from real world (e.g., electronic health records, and health care claims) and experiments that profile the molecular state of human cells and tissues by interactomics, transcriptomics, genomics, proteomics, and metabolomics for personalized drug discovery and precise patient care. The primary goal of the scholar's lab is to combine tools from genomics, network medicine, bioinformatics, computational biology, chemical biology, and experimental pharmacology and systems biology assays (e.g., single cell sequencing and iPS-derived cardiomyocytes), to address the challenging questions toward understanding of various human complex diseases (e.g., cardio-oncology, pulmonary vascular diseases, and cancer), which could have a major impact in identifying novel real-world data-driven diagnostic biomarkers and therapeutic targets for precision medicine.
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
单核多组学图谱揭示阿尔茨海默病及相关痴呆症下的人脑小脑
Nature Communications
IF15.7
阿尔茨海默病靶点与药物发现:利用多组学和电子健康数据
阿尔茨海默病中药物重定位治疗:通用名药物与专利保护药物的对比分析(2016–2025)
脑脊液与血浆的关联性将分析物与阿尔茨海默病风险老年人群的认知衰退联系起来
Getsy, P.M.; May, W.J.; Baby, S.M.; Coffee, G.A.; Qiu, Y.; Cheng, F.; Bates, J.N.; Lewis, S.J. 阿片类药物诱导的呼吸抑制中胆碱能受体信号转导过程在特定方面的作用。 Pharmaceuticals, 2026; under review. [CrossRef]
Pharmaceuticals
IF4.8
病毒诱导的ISG15去共价修饰扰乱固有免疫和细胞代谢
Immunity
IF26.3
L-半胱氨酸乙酯可能通过激活毒蕈碱受体克服吗啡诱导的呼吸抑制
Pharmaceuticals
IF4.8
CHCHD10 通过表观遗传重塑减轻阿尔茨海默病相关表型,并与直接重编程神经元相关联
Advanced Science
IF14.1
GABA信号激活通过髓源性抑制细胞驱动雌性小鼠胶质母细胞瘤的进展
Nature Cancer
IF28.5
结合来自不同人群的xQTL和全基因组关联研究,可提高可成药基因的发现效率
Nature Communications
IF15.7
用于分子靶标和性质预测的多视图生物医学基础模型
Advanced Science
IF14.1
作者更正:PPIA决定NRF2的稳定性以促进肺癌进展
Nature Communications
IF15.7
阿尔茨海默病临床试验的全球化:当前特征与未来目标
量子框架在实用级量子处理器上对蛋白质结合位点结构预测的应用
Advanced Science
IF14.1
全基因组关联研究(GWAS)和亚阈值位点的分析揭示了精神分裂症遗传风险下树突发育和形态功能障碍的发现。
Advanced Science
IF14.1
发现与泛癌患者左心室心功能障碍相关的血浆蛋白和代谢物
CARDIO-ONCOLOGY
IF3.2
ALZHEIMERS & DEMENTIA
IF11.1
神经发育和衰老中的Ras,RhoA和血管药理学

